{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:55:20Z","timestamp":1780476920372,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000152","name":"Canadian Hemophilia Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021338","name":"Margaret M. and Albert B. Alkek Department of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009776","name":"McMaster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ab.2024.115714","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:27:18Z","timestamp":1731047238000},"page":"115714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of an assay to quantify tranexamic acid levels in plasma"],"prefix":"10.1016","volume":"697","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0504-3064","authenticated-orcid":false,"given":"Paul Y.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Vong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2024.115714_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.ab.2024.115714_bib2","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/jth.14215","article-title":"Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke","volume":"16","author":"Henderson","year":"2018","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ab.2024.115714_bib3","doi-asserted-by":"crossref","first-page":"26150","DOI":"10.1016\/S0021-9258(18)35729-6","article-title":"Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro","volume":"267","author":"Fredenburgh","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib4","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1074\/jbc.272.4.2183","article-title":"A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain","volume":"272","author":"Horrevoets","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib5","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib6","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1074\/jbc.M111.317719","article-title":"A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator","volume":"287","author":"Kim","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib7","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/S0021-9258(18)32614-0","article-title":"The binding of human plasminogen to fibrin and fibrinogen","volume":"258","author":"Lucas","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jth.13957","article-title":"Measuring fibrinolysis: from research to routine diagnostic assays","volume":"16","author":"Longstaff","year":"2018","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ab.2024.115714_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-5793(85)81150-9","article-title":"C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen","volume":"182","author":"Christensen","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ab.2024.115714_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/jmbi.1996.0238","article-title":"The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator","volume":"258","author":"Lamba","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2024.115714_bib11","doi-asserted-by":"crossref","first-page":"21713","DOI":"10.1074\/jbc.272.35.21713","article-title":"Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors","volume":"272","author":"Renatus","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0036-1598001","article-title":"Diagnosis and treatment of hyperfibrinolysis in trauma (A European perspective)","volume":"43","author":"Gall","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ab.2024.115714_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00508-017-1194-y","article-title":"Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis","volume":"129","author":"Pabinger","year":"2017","journal-title":"Wien Klin. Wochenschr."},{"key":"10.1016\/j.ab.2024.115714_bib14","doi-asserted-by":"crossref","first-page":"iii18","DOI":"10.1093\/bja\/aew358","article-title":"Perioperative management of the bleeding patient","volume":"117","author":"Ghadimi","year":"2016","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ab.2024.115714_bib15","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1016\/S2352-3026(23)00119-9","article-title":"Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial","volume":"10","author":"Ragni","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ab.2024.115714_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(10)60939-7","article-title":"Antifibrinolytic therapy: new data and new concepts","volume":"376","author":"Levy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ab.2024.115714_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res. Pract. Thromb Haemost."},{"key":"10.1016\/j.ab.2024.115714_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2302\/kjm.11.105","article-title":"Amino-methyl-cyclohexane-carboxylic acid: AMCHA. A new potent inhibitor of fibrinolysis","volume":"11","author":"Okamoto","year":"1962","journal-title":"Keio J. Med."},{"key":"10.1016\/j.ab.2024.115714_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ab.2024.115714_bib20","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ab.2024.115714_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamic acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2024.115714_bib22","series-title":"WHO Model List of Essential Medicine : 17th List","author":"Organization","year":"2011"},{"key":"10.1016\/j.ab.2024.115714_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ab.2024.115714_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40560-016-0201-0","article-title":"Tranexamic acid and trauma-induced coagulopathy","volume":"5","author":"Nishida","year":"2017","journal-title":"J. intensive care"},{"key":"10.1016\/j.ab.2024.115714_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological Investigation of the Prevalence of von Willebrand's Disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.ab.2024.115714_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ab.2024.115714_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBC.0000000000000789","article-title":"What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies","volume":"30","author":"Picetti","year":"2019","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ab.2024.115714_bib28","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00000539-200105000-00010","article-title":"Plasma tranexamic acid concentrations during cardiopulmonary bypass","volume":"92","author":"Fiechtner","year":"2001","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ab.2024.115714_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","article-title":"Tranexamic acid: a clinical review","volume":"47","author":"Ng","year":"2015","journal-title":"Anaesthesiol. Intensive Ther."},{"key":"10.1016\/j.ab.2024.115714_bib30","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1365-2044.2012.07266.x","article-title":"Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass","volume":"67","author":"Sharma","year":"2012","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ab.2024.115714_bib31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1213\/ANE.0000000000002724","article-title":"Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen","volume":"127","author":"Jerath","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ab.2024.115714_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cca.2010.01.005","article-title":"A validated assay for the quantitative analysis of tranexamic acid in human serum by liquid chromatography coupled with electrospray ionization mass spectrometry","volume":"411","author":"Grassin","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ab.2024.115714_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.microc.2017.06.020","article-title":"Analytical methods for quantification of tranexamic acid in biological fluids: a review","volume":"134","author":"Silva","year":"2017","journal-title":"Microchem. J."},{"key":"10.1016\/j.ab.2024.115714_bib34","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1074\/jbc.272.4.2176","article-title":"Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease","volume":"272","author":"Horrevoets","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib35","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1538-7836.2007.02426.x","article-title":"The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease","volume":"5","author":"Kim","year":"2007","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ab.2024.115714_bib36","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1074\/jbc.272.4.2176","article-title":"Production and characterization of recombinant human plasminogen(S741C-Fluorescein)","volume":"272","author":"Horrevoets","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2024.115714_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ab.2007.09.034","article-title":"An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma","volume":"372","author":"Kim","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2024.115714_bib38","first-page":"109","article-title":"Functional testing for tranexamic acid duration of action using modified viscoelastometry","volume":"48","author":"Kammerer","year":"2021","journal-title":"Transfusions. und Immunhamatol."},{"issue":"6","key":"10.1016\/j.ab.2024.115714_bib39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jtha.2024.02.007","article-title":"A specific fluorescence resonance energy quenching-based biosensor for measuring thrombin activity in whole blood","volume":"22","author":"Dai","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ab.2024.115714_bib40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ab.2004.04.007","article-title":"A functional assay for measuring activated thrombin-activatable fibrinolysis inhibitor in plasma","volume":"330","author":"Neill","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2024.115714_bib41","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2008.03067.x","article-title":"Activated thrombin-activatable fibrinolysis inhibitor is generated in vivo at levels that can substantially affect fibrinolysis in chimpanzees in response to thrombin generation","volume":"6","author":"Kim","year":"2008","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ab.2024.115714_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11239-011-0676-4","article-title":"Thrombin-activatable fibrinolysis inhibitor is activated in vivo in a baboon model of Escherichia coli induced sepsis","volume":"33","author":"Kim","year":"2012","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ab.2024.115714_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.0022-2720.2004.01377.x","article-title":"Minimizing photobleaching during confocal microscopy of fluorescent probes bound to chromatin: role of anoxia and photon flux","volume":"215","author":"Bernas","year":"2004","journal-title":"J. Microsc."},{"key":"10.1016\/j.ab.2024.115714_bib44","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/002215549904700910","article-title":"Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates","volume":"47","author":"Panchuk-Voloshina","year":"1999","journal-title":"J. Histochem. Cytochem."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269724002586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269724002586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T13:42:47Z","timestamp":1733319767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269724002586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":44,"alternative-id":["S0003269724002586"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2024.115714","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an assay to quantify tranexamic acid levels in plasma","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2024.115714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115714"}}